CSL Behring
Study of Efficacy and Safety of Privigen in Subjects With Chronic Inflammatory Demyelinating Polyneuropathy
- Conditions
- Chronic Inflammatory Demyelinating Polyneuropathy
- First Posted Date
- 2010-08-19
- Last Posted Date
- 2024-06-25
- Lead Sponsor
- CSL Behring
- Target Recruit Count
- 31
- Registration Number
- NCT01184846
- Locations
- 🇵🇱
Study Site, Wroclaw, Poland
Retrospective Chart Review of Subcutaneous IgG Use in Infants
- Conditions
- Primary Immune Deficiency
- First Posted Date
- 2010-07-20
- Last Posted Date
- 2011-02-11
- Lead Sponsor
- CSL Behring
- Target Recruit Count
- 27
- Registration Number
- NCT01166074
- Locations
- 🇺🇸
Children's Hospital of Los Angeles, Los Angeles, California, United States
🇺🇸University of South Florida, Tampa, Florida, United States
🇺🇸Midwest Immunology Clinic, Plymouth, Minnesota, United States
Patient Registry Study of Berinert® in Normal Clinical Practice
- Conditions
- Includes: Hereditary Angioedema
- First Posted Date
- 2010-04-22
- Last Posted Date
- 2014-06-09
- Lead Sponsor
- CSL Behring
- Target Recruit Count
- 318
- Registration Number
- NCT01108848
- Locations
- 🇺🇸
United States, Arizona, Scottsdale, Arizona, United States
🇺🇸United States, California, San Diego, California, United States
🇺🇸United States, Georgia, Atlanta, Georgia, United States
Rabies Immune Plasma Booster Study
- Conditions
- Rabies
- First Posted Date
- 2010-02-05
- Last Posted Date
- 2015-09-07
- Lead Sponsor
- CSL Behring
- Target Recruit Count
- 491
- Registration Number
- NCT01063140
- Locations
- 🇺🇸
CSL Donor Plasma Center, Salt Lake City, Utah, United States
Quality of Life Study of Helixate NexGen
- Conditions
- Hemophilia A
- First Posted Date
- 2010-01-21
- Last Posted Date
- 2015-03-20
- Lead Sponsor
- CSL Behring
- Target Recruit Count
- 78
- Registration Number
- NCT01053715
- Locations
- 🇦🇹
CSLB Study Site 22, Graz, Austria
🇦🇹CSLB Study Site 26, Grieskirchen, Austria
🇦🇹CSLB Study Site 24, Innsbruck, Austria
Observational Study of Prophylaxis and Treatment of Acute Perioperative Bleeding With Beriplex® P/N (Probe Study)
- Conditions
- Coagulation Protein DisordersPerioperative CareBlood Loss, Surgical
- First Posted Date
- 2010-01-21
- Last Posted Date
- 2017-10-03
- Lead Sponsor
- CSL Behring
- Target Recruit Count
- 445
- Registration Number
- NCT01053169
- Locations
- 🇬🇧
Royal Blackburn Hospital, Blackburn, United Kingdom
🇬🇧Blackpool, Blackpool, United Kingdom
🇬🇧Addenbrokes, Cambridge, United Kingdom
Health Related Quality of Life of Youth and Young Adults With Hemophilia A
- Conditions
- Hemophilia A
- First Posted Date
- 2009-12-18
- Last Posted Date
- 2013-12-10
- Lead Sponsor
- CSL Behring
- Target Recruit Count
- 48
- Registration Number
- NCT01034904
- Locations
- 🇨🇦
Sick Kids Hospital, Toronto, Ontario, Canada
🇨🇦CHU Sainte-Justine, Montreal, Quebec, Canada
An Open Enrollment Study of Factor XIII Concentrate in Subjects With Congenital Factor XIII Deficiency
- Conditions
- Factor XIII Deficiency
- First Posted Date
- 2009-07-24
- Last Posted Date
- 2012-10-12
- Lead Sponsor
- CSL Behring
- Target Recruit Count
- 61
- Registration Number
- NCT00945906
- Locations
- 🇺🇸
Study Site, Houston, Texas, United States
🇺🇸Study site, Milwaukee, Wisconsin, United States
Study of a pd VWF/FVIII Concentrate, Biostate®, in Subjects With Von Willebrand Disease
- Conditions
- Von Willebrand Disease
- First Posted Date
- 2009-07-17
- Last Posted Date
- 2017-10-03
- Lead Sponsor
- CSL Behring
- Target Recruit Count
- 22
- Registration Number
- NCT00941616
- Locations
- 🇺🇦
Study Site, Lviv, Ukraine
Fibrinogen Concentrate (Human) - Efficacy and Safety Study
- Conditions
- AfibrinogenemiaHypofibrinogenemiaFibrinogen Deficiency
- First Posted Date
- 2009-06-09
- Last Posted Date
- 2023-02-06
- Lead Sponsor
- CSL Behring
- Registration Number
- NCT00916656